Estrada, Baby Girl .

HRN: 27-43-83  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/14/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/14/2025
07/21/2025
IV
35mg
Q24h
MAS
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  PneumoniaBloodstream    Compliance to guidelines: